Welcome to the Precision Medicine Podcast, where experts come to discuss the problems oncologists, reference labs, and payers face as precision medicine grows, and consider solutions for advancing the quality of patient-centered cancer care.
Bill Bonello and Clynt Taylor Examine the Future of Precision Medicine and How to Provide Better Access to More Patients
Bill Bonello, president of NeoGenomics Informatics, and Clynt Taylor, president of Trapelo Health, discuss challenges in precision medicine and how evidence-based technologies can help deliver more appropriate, value-based care to more patients.As a subtext to the discussion is the recent acquisition of Trapelo Health, creator of clinical decision-making platform Trapelo, by NeoGenomics Informatics, provider of bioinformatics services. This acquisition is aimed at improving access to precision medicine testing and treatment. Read the full summary and learn more about Trapelo here (https://www.trapelohealth.com/precision-medicine-testing).
Dr. Caroline Carney and Clynt Taylor Discuss Managing the Total Cost of Care in Precision Medicine
In this notable episode, Dr. Caroline Carney, Chief Medical Officer at Magellan Health, and Clynt Taylor, CEO at Trapelo Health, join us to discuss how collaborative technologies can help payers more effectively manage the cost of precision oncology while delivering the best outcomes for patients. Read the full summary (https://www.trapelohealth.com/magellan-trapelo-precision-medicine).
Dr. F. Anthony Greco Explains How Precision Medicine Has Led to Better Treatments for Cancers of Unknown Origins
In this episode, Dr. F. Anthony Greco, medical oncologist at Tennessee Oncology, discusses the role that precision medicine has played in improving our diagnosis and treatment of cancer.
Dr. Gabriel Bien-Willner Part 2: Helping Payers Adapt to the Paradigm Shift of Precision Medicine
In this Part 2 podcast (https://www.trapelohealth.com/precision-oncology-prior-auth) featuring Dr. Gabriel A. Bien-Willner, Medical Director of the MolDX programat Palmetto GBA, we dive into the core challenges that payers face in navigating the explosion of precision medicine tests and treatments, and specifically how the prior authorization process can be streamlined by keeping payers updated on changes in coverage policy for new genes or CDx.
Be sure to tune in to Part 1 with Dr. Bien-Willner (https://www.trapelohealth.com/reimbursement-for-genetic-testing) who speaks about reshaping reimbursement policies for genetic and genomic testing.
AbbVie’s Christopher Boone Integrates Real-World Data with Precision Medicine for Better Patient Outcomes
Christopher Boone, Vice President and Global Head of Health Economics & Outcomes Research at AbbVie, shares his thoughts on how using data to understand a patient’s real-world environment can expand the practice of Precision Medicine.
Precision Medicine is Coming Faster Than You Think: Guests Rob Metcalf and Clynt Taylor
It is fitting that our first guests on Season 3 of the Precision Medicine Podcast are Rob Metcalf, CEO of Concert Genetics and Clynt Taylor, CEO of Trapelo Health who are both innovators in precision medicine technology. What we learn from them in this episode is that after 20 years of hearing about the “promise of precision medicine,” technology has reached a critical point where it can begin to accelerate that progress. Read the full summary, listen and learn more here. (https://www.trapelohealth.com/precision-medicine-technology)
Excellent source of information spanning a wide range of stake holders across the spectrum of precision medicine.
Pretty good but “unempathetic ‘yeahs’”
Generally pretty good content but have listened to multiple podcasts where moderator responds to really deep life and death statements from guests (eg ROS1ders talking about the ends of their lives, women leadership expert talking about under representation) with “yeah...<next question>.” I just want moderator to know that that’s happening and consider finding a more respectful and empathetic way to keep things moving. But keep up the podcast it’s good and needed - maybe could be a bit deeper as audience is expert not intro.
this is a MUST LISTEN !
HIGHLY valuable information and insights for the entire cancer ecosystem -- patient, caregiver, family, friends, et. al. the book is even better!